decitabine

NDC 0143-9385 · Hikma Pharmaceuticals USA Inc.

Generic namedecitabine

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DECITABINE

Strength50 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

0143-9385-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9385-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

J0894 — Injection, decitabine, 1 mg Medicare Part B payment limit (ASP + 6%): $1.06

FDA lists these products with the same active ingredient.

16729-224 — decitabine, 25021-219 — Decitabine, 31722-304 — Decitabine, 43598-427 — Decitabine, 55111-556 — Decitabine, 55150-376 — Decitabine, 64842-0727 — CEDAZURIDINE and DECITABINE, 67184-0535 — decitabine, 67457-316 — decitabine, 68001-573 — decitabine, 68001-618 — Decitabine, 68001-642 — Decitabine, 68083-528 — decitabine, 70121-1644 — decitabine, 71288-119 — Decitabine, 72162-2634 — Decitabine, 72205-031 — Decitabine, 72205-036 — Decitabine, 72603-107 — Decitabine, 75834-190 — decitabine

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.